Literature DB >> 14991955

Preventive effect of Ganfujian granule on experimental hepatocarcinoma in rats.

Yan Qian1, Chang-Quan Ling.   

Abstract

AIM: To investigate the inhibitory effect of dietary and medicinal formula Ganfujian granule on diethylnitrosamine (DEN)-induced hepatocarcinoma in rats.
METHODS: Male SD rats had free access to water containing 0.1 g/L DEN for 16 weeks, during which the rats fed with standard diet or administration of Ganfujian granule (30.4 g/Kg in diet). At weeks 4, 8, 12 and 16 of hepatocarcinogenesis 5 rats of each group were sacrificed, and at week 20 another 30 rats were sacrificed from each group. The end point for survival observation was at week 28. Immunochemistry methods were used to examine the effect of Ganfujian granule on the process of hepatocarcinogenesis including proliferation of hepatocytes and cell cycle modulation.
RESULTS: Ganfujian granule could reduce and delay the incidence of hepatocarcinoma in rats and prolong the survival of animals. In addition, Ganfujian granule had a marked inhibitory effect on high expression of cyclin dependent kinase (CDK4) during the whole process of hepatocarcinogenesis and cyclin D1 at week 16 and the number of proliferating cell nuclear antigen (PCNA) positive cells in different stages of hepatocarcinogenesis.
CONCLUSION: Ganfujian granule can reduce and delay the incidence of hepatocarcinoma in rats by exerting direct or indirect effects on cell cycle and inhibiting uncontrolled proliferation of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991955      PMCID: PMC4716926          DOI: 10.3748/wjg.v10.i5.755

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  6 in total

1.  Traditional Chinese medicine for primary liver cancer.

Authors:  Zuo-Qing Li
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

Review 2.  Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma.

Authors:  M H Chang; D S Chen
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  1999-12

3.  Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

Authors:  Jin-Hui Yuan; Ru-Ping Zhang; Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Dan Luo; Yong Xie; Hong Xie
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

Review 4.  Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection.

Authors:  V Baffis; I Shrier; A H Sherker; A Szilagyi
Journal:  Ann Intern Med       Date:  1999-11-02       Impact factor: 25.391

Review 5.  Intervention studies on cancer.

Authors:  K J Young; P N Lee
Journal:  Eur J Cancer Prev       Date:  1999-04       Impact factor: 2.497

Review 6.  [Hepatocellular carcinoma].

Authors:  A Lemoine; D Azoulay; M Jezequel-Cuer; B Debuire
Journal:  Pathol Biol (Paris)       Date:  1999-11
  6 in total
  10 in total

Review 1.  Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside.

Authors:  Bing Hu; Shuang-Shuang Wang; Qin Du
Journal:  World J Hepatol       Date:  2015-05-28

2.  A survey on herbal management of hepatocellular carcinoma.

Authors:  Nabil Mohie Abdel-Hamid; Maiiada Hasan Nazmy; Ahmed Wahid Mahmoud; Michael Atef Fawzy; Marco Youssof
Journal:  World J Hepatol       Date:  2011-07-27

3.  DEN+2-AAF-induced multistep hepatotumorigenesis in Wistar rats: supportive evidence and insights.

Authors:  Shabnam Malik; Shilpa Bhatnagar; Naveen Chaudhary; Deepshikha Pande Katare; S K Jain
Journal:  Protoplasma       Date:  2012-03-29       Impact factor: 3.356

4.  Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats.

Authors:  Salim S Al-Rejaie; Abdulaziz M Aleisa; Abdulaziz A Al-Yahya; Saleh A Bakheet; Abdulmalik Alsheikh; Amal G Fatani; Othman A Al-Shabanah; Mohamed M Sayed-Ahmed
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

5.  Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling.

Authors:  Mohamed M Sayed-Ahmed; Abdulaziz M Aleisa; Salim S Al-Rejaie; Abdulaziz A Al-Yahya; Othman A Al-Shabanah; Mohamed M Hafez; Mahmoud N Nagi
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

6.  Cytotoxic and apoptotic activities of Amorphophallus campanulatus tuber extracts against human hepatoma cell line.

Authors:  P N Ansil; P J Wills; R Varun; M S Latha
Journal:  Res Pharm Sci       Date:  2014 Jul-Aug

7.  Antioxidant and hepatoprotective potential of Lawsonia inermis L. leaves against 2-acetylaminofluorene induced hepatic damage in male Wistar rats.

Authors:  Manish Kumar; Paramjeet Kaur; Madhu Chandel; Amrit Pal Singh; Arpana Jain; Satwinderjeet Kaur
Journal:  BMC Complement Altern Med       Date:  2017-01-18       Impact factor: 3.659

8.  Phytofabrication of Silver nanoparticles: Novel Drug to overcome hepatocellular ailments.

Authors:  Asha Singh; Mohd Yaqoob Dar; Beenu Joshi; Bhawna Sharma; Sadhana Shrivastava; Sangeeta Shukla
Journal:  Toxicol Rep       Date:  2018-03-01

9.  Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway.

Authors:  Deepak Bhatia; Roslin J Thoppil; Animesh Mandal; Karishma A Samtani; Altaf S Darvesh; Anupam Bishayee
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

10.  Lessons learnt from evidence-based approach of using chinese herbal medicines in liver cancer.

Authors:  Zhan Zheng; William Chi-Shing Cho; Ling Xu; Juyong Wang; Daniel Man-Yuen Sze
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-29       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.